A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcoma
This study is currently recruiting participants.
Verified by National Cancer Institute (NCI), December 2008
Last Updated: December 4, 2008